Literature DB >> 28816019

iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.

Jingjing Zhang1,2, Chunchun Zhi3, Fuxi Zhen4, Xiaoqin Yuan3, Chunhua Jiao5, Hong Zhu5, Hui Zhu1, Yadong Feng6,7.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide and is the fourth most lethal cancer in China. Little is known about the proteome of high grade esophageal squamous intraepithelial neoplasia (HGN), which is a premalignant lesion of ESCC. A quantitative proteomic analysis using an isobaric tag for relative and absolute quantification (iTRAQ) approach is used to characterize the protein expression profiles in HGN. Among the 3156 identified proteins, a total of 236 proteins are discovered to be differentially expressed. Compared with paired normal esophageal epithelial tissues, 138 proteins are upregulated and 98 proteins are downregulated in HGN. Bioinformatics analyses are performed according to gene ontology, clusters of orthologous groups, and kyoto encyclopedia of genes and genomes enrichment analyses. Six differentially expressed proteins are chosen and validated by Western blotting. The results of the study increase our understanding of early tumorigenesis during ESCC, and provide insights into the proteome at the initial stages of the disease that can be used to identify potential biomarkers for early diagnosis and for therapeutic targets.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomarkers; Esophageal squamous epithelium; High grade intraepithelial neoplasia; Proteome; iTRAQ

Mesh:

Substances:

Year:  2017        PMID: 28816019     DOI: 10.1002/prca.201600167

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  4 in total

1.  Suppression of OSCC malignancy by oral glands derived-PIP identified by iTRAQ combined with 2D LC-MS/MS.

Authors:  Qibo Wang; Yuan Zhi; Wenhao Ren; Shaoming Li; Zhichao Dou; Xiaoming Xing; Xinyu Quan; Yuting Wang; Chunmiao Jiang; Xiao Liang; Ling Gao; Keqian Zhi
Journal:  J Cell Physiol       Date:  2019-01-28       Impact factor: 6.384

2.  ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Xiao-Li Ma; Hua Yao; Xiao Wang; Yu Wei; Lei-Yu Cao; Qian Zhang; Li Zhang
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

3.  Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma.

Authors:  Wei Liu; Yongping Cui; Wen Liu; Zhihua Liu; Liyan Xu; Enmin Li
Journal:  Cancer Biol Med       Date:  2022-03-11       Impact factor: 4.248

Review 4.  Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.

Authors:  Manoj Kumar Kashyap; Omar Abdel-Rahman
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.